The Oncosearch | Oncotarget

Does afatinib plus bevacizumab combination therapy induce positive conversion of T790M in previously-negative patients? Research Paper

Akito Hata, Nobuyuki Katakami, Reiko Kaji, Toshihide Yokoyama, Toshihiko Kaneda, Motohiro Tamiya, Takako Inoue, Hiromi Kimura, Yukihiro Yano, Daisuke Tamura, Satoshi Morita, Shunichi Negoro

Published Oct 5, 2018 · Vol. 9, No. 78 · pp. 34765-34771

Estrogen receptor-beta is a potential target for triple negative breast cancer treatment Research Paper

David Austin, Nalo Hamilton, Yahya Elshimali, Richard Pietras, Yanyuan Wu, Jaydutt Vadgama

Published Sep 21, 2018 · Vol. 9, No. 74 · pp. 33912-33930

Development of parallel reaction monitoring (PRM)-based quantitative proteomics applied to HER2-Positive breast cancer Research Paper

Mathilde Guerin, Anthony GonÃ§alves, Yves Toiron, Emilie Baudelet, Matthieu Pophillat, Samuel Granjeaud, Patrick Fourquet, William Jacot, Carole Tarpin, Renaud Sabatier, Emilie Agavnian, Pascal Finetti, JosÃ© Adelaide, Daniel Birnbaum, Christophe Ginestier, Emmanuelle Charafe-Jauffret, Patrice Viens, FranÃ§ois Bertucci, Jean-Paul Borg, Luc Camoin

Published Sep 18, 2018 · Vol. 9, No. 73 · pp. 33762-33777

CDK4/6 inhibitors in hormone receptor-positive, human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancer: Are we at the finish line? Editorial

Clinton Yam, Mien-Chie Hung, Gabriel N. Hortobagyi

Published Sep 13, 2018 · Vol. 9, No. 76 · pp. 34193-34195

RN765C, a low affinity EGFR antibody drug conjugate with potent anti-tumor activity in preclinical solid tumor models Priority Research Paper

Oi Kwan Wong, Thomas-Toan Tran, Wei-Hsien Ho, Meritxell Galindo Casas, Melinda Au, Marjorie Bateman, Kevin C. Lindquist, Arvind Rajpal, David L. Shelton, Pavel Strop, Shu-Hui Liu

Published Sep 11, 2018 · Vol. 9, No. 71 · pp. 33446-33458

Outcome analysis of Phase I trial patients with metastatic KRAS and/or TP53 mutant non-small cell lung cancer Research Paper

Yudong Wang, Zhijie Wang, Sarina Piha-Paul, Filip Janku, Vivek Subbiah, Naiyi Shi, Kenneth Hess, Russell Broaddus, Baoen Shan, Aung Naing, David Hong, Apostolia M. Tsimberidou, Daniel Karp, Charles Lu, Vali Papadimitrakopoulou, John Heymach, Funda Meric-Bernstam, Siqing Fu

Published Sep 7, 2018 · Vol. 9, No. 70 · pp. 33258-33270

Involvement of GLUT1-mediated glucose transport and metabolism in gefitinib resistance of non-small-cell lung cancer cells Research Paper

Shuhei Suzuki, Masashi Okada, Hiroyuki Takeda, Kenta Kuramoto, Tomomi Sanomachi, Keita Togashi, Shizuka Seino, Masahiro Yamamoto, Takashi Yoshioka, Chifumi Kitanaka

Published Aug 24, 2018 · Vol. 9, No. 66 · pp. 32667-32679

A novel fatty acid-binding protein 5-estrogen-related receptor Î± signaling pathway promotes cell growth and energy metabolism in prostate cancer cells Research Paper

Shogo Senga, Koichiro Kawaguchi, Narumi Kobayashi, Akira Ando, Hiroshi Fujii

Published Aug 3, 2018 · Vol. 9, No. 60 · pp. 31753-31770

APOBEC3B gene expression as a novel predictive factor for pathological complete response to neoadjuvant chemotherapy in breast cancer Research Paper

Yoshitaka Fujiki, Yutaka Yamamoto, Aiko Sueta, Mutsuko Yamamoto-Ibusuki, Lisa Goto-Yamaguchi, Mai Tomiguchi, Takashi Takeshita, Hirotaka Iwase

Published Jul 17, 2018 · Vol. 9, No. 55 · pp. 30513-30526

Positive crosstalk between EGFR and the TF-PAR2 pathway mediates resistance to cisplatin and poor survival in cervical cancer Research Paper

Vitor Hugo de Almeida, Isabella dos Santos GuimarÃ£es, Lucas R. Almendra, Araci M.R. Rondon, Tatiana M. Tilli, AndrÃ©ia C. de Melo, Cinthya Sternberg, Robson Q. Monteiro

Published Jul 17, 2018 · Vol. 9, No. 55 · pp. 30594-30609

The DNA-polymorphism rs849142 is associated with skin toxicity induced by targeted anti-EGFR therapy using cetuximab Research Paper

Matthias F. Froelich, Sebastian Stintzing, JÃ¶rg Kumbrink, Thomas G.P. GrÃ¼newald, Ulrich Mansmann, Volker Heinemann, Thomas Kirchner, Andreas Jung

Published Jul 13, 2018 · Vol. 9, No. 54 · pp. 30279-30288

CAPER as a therapeutic target for triple negative breast cancer Research Paper

Mallory C. Campbell, Laura Pontiggia, Ashley Y. Russell, Roland Schwarting, Jeanette Camacho, Jean-Francois Jasmin, Isabelle Mercier

Published Jul 13, 2018 · Vol. 9, No. 54 · pp. 30340-30354

Loss of KIBRA function activates EGFR signaling by inducing AREG Research Paper

Ashley L. Mussell, Kayla E. Denson, He Shen, Yanmin Chen, Nuo Yang, Costa Frangou, Jianmin Zhang

Published Jul 6, 2018 · Vol. 9, No. 52 · pp. 29975-29984

A CARP-1 functional mimetic compound is synergistic with BRAF-targeting in non-small cell lung cancers Research Paper

Vino T. Cheriyan, Hashem Alsaab, Sreeja Sekhar, Jaganathan Venkatesh, Arindam Mondal, Imran Vhora, Samaresh Sau, Magesh Muthu, Lisa A. Polin, Edi Levi, Gerold Bepler, Arun K. Iyer, Mandip Singh, Arun K. Rishi

Published Jul 3, 2018 · Vol. 9, No. 51 · pp. 29680-29697

Treatment of EGFR mutationâ€“positive nonâ€“small cell lung cancer complicated by Trousseau syndrome with gefitinib followed by osimertinib: a case report Case Report

Yoshikane Nonagase, Masayuki Takeda, Kaoru Tanaka, Hidetoshi Hayashi, Tsutomu Iwasa, Kazuhiko Nakagawa

Published Jun 29, 2018 · Vol. 9, No. 50 · pp. 29532-29535

The TGFÎ±-EGFR-Akt signaling axis plays a role in enhancing proinflammatory chemokines in triple-negative breast cancer cells Research Paper

Rosa Mistica C. Ignacio, Carla R. Gibbs, Eun-Sook Lee, Deok-Soo Son

Published Jun 29, 2018 · Vol. 9, No. 50 · pp. 29286-29303

Clinical significance of repeat rebiopsy in detecting the EGFR T790M secondary mutation in patients with non-small cell lung cancer Clinical Research Papers

Eiki Ichihara, Katsuyuki Hotta, Toshio Kubo, Tsukasa Higashionna, Kiichiro Ninomiya, Kadoaki Ohashi, Masahiro Tabata, Yoshinobu Maeda, Katsuyuki Kiura

Published Jun 29, 2018 · Vol. 9, No. 50 · pp. 29525-29531

Integrated treatment using intraperitoneal radioimmunotherapy and positron emission tomography-guided surgery with ⁶⁴Cu-labeled cetuximab to treat early- and late-phase peritoneal dissemination in human gastrointestinal cancer xenografts Research Paper

Yukie Yoshii, Mitsuyoshi Yoshimoto, Hiroki Matsumoto, Hideaki Tashima, Yuma Iwao, Hiroyuki Takuwa, Eiji Yoshida, Hidekatsu Wakizaka, Taiga Yamaya, Ming-Rong Zhang, Aya Sugyo, Sayaka Hanadate, Atsushi B. Tsuji, Tatsuya Higashi

Published Jun 22, 2018 · Vol. 9, No. 48 · pp. 28935-28950

EGFR overexpression is not common in patients with head and neck cancer. Cell lines are not representative for the clinical situation in this indication Research Paper

Sami Sebastian Khaznadar, Martin Khan, Elke Schmid, Sebastian Gebhart, Eva-Tessina Becker, Thomas Krahn, Oliver von Ahsen

Published Jun 22, 2018 · Vol. 9, No. 48 · pp. 28965-28975

T790M mutant copy number quantified via ddPCR predicts outcome after osimertinib treatment in lung cancer Research Paper

Jacky Yu-Chung Li, James Chung-Man Ho, Kam-Hung Wong

Published Jun 15, 2018 · Vol. 9, No. 46 · pp. 27929-27939

Publication Alerts

European Cancer and Oncology Congress

Post-Publication Promotion

Search Oncotarget

Does afatinib plus bevacizumab combination therapy induce positive conversion of T790M in previously-negative patients? Research Paper

Estrogen receptor-beta is a potential target for triple negative breast cancer treatment Research Paper

Development of parallel reaction monitoring (PRM)-based quantitative proteomics applied to HER2-Positive breast cancer Research Paper

CDK4/6 inhibitors in hormone receptor-positive, human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancer: Are we at the finish line? Editorial

RN765C, a low affinity EGFR antibody drug conjugate with potent anti-tumor activity in preclinical solid tumor models Priority Research Paper

Outcome analysis of Phase I trial patients with metastatic KRAS and/or TP53 mutant non-small cell lung cancer Research Paper

Involvement of GLUT1-mediated glucose transport and metabolism in gefitinib resistance of non-small-cell lung cancer cells Research Paper

A novel fatty acid-binding protein 5-estrogen-related receptor Î± signaling pathway promotes cell growth and energy metabolism in prostate cancer cells Research Paper

APOBEC3B gene expression as a novel predictive factor for pathological complete response to neoadjuvant chemotherapy in breast cancer Research Paper

Positive crosstalk between EGFR and the TF-PAR2 pathway mediates resistance to cisplatin and poor survival in cervical cancer Research Paper

The DNA-polymorphism rs849142 is associated with skin toxicity induced by targeted anti-EGFR therapy using cetuximab Research Paper

CAPER as a therapeutic target for triple negative breast cancer Research Paper

Loss of KIBRA function activates EGFR signaling by inducing AREG Research Paper

A CARP-1 functional mimetic compound is synergistic with BRAF-targeting in non-small cell lung cancers Research Paper

Treatment of EGFR mutationâ€“positive nonâ€“small cell lung cancer complicated by Trousseau syndrome with gefitinib followed by osimertinib: a case report Case Report

The TGFÎ±-EGFR-Akt signaling axis plays a role in enhancing proinflammatory chemokines in triple-negative breast cancer cells Research Paper

Clinical significance of repeat rebiopsy in detecting the EGFR T790M secondary mutation in patients with non-small cell lung cancer Clinical Research Papers

Integrated treatment using intraperitoneal radioimmunotherapy and positron emission tomography-guided surgery with ⁶⁴Cu-labeled cetuximab to treat early- and late-phase peritoneal dissemination in human gastrointestinal cancer xenografts Research Paper

EGFR overexpression is not common in patients with head and neck cancer. Cell lines are not representative for the clinical situation in this indication Research Paper

T790M mutant copy number quantified via ddPCR predicts outcome after osimertinib treatment in lung cancer Research Paper

Publication Alerts

European Cancer and Oncology Congress

Oncoscience

Post-Publication Promotion

Search Oncotarget

Does afatinib plus bevacizumab combination therapy induce positive conversion of T790M in previously-negative patients? Research Paper

Estrogen receptor-beta is a potential target for triple negative breast cancer treatment Research Paper

Development of parallel reaction monitoring (PRM)-based quantitative proteomics applied to HER2-Positive breast cancer Research Paper

CDK4/6 inhibitors in hormone receptor-positive, human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancer: Are we at the finish line? Editorial

RN765C, a low affinity EGFR antibody drug conjugate with potent anti-tumor activity in preclinical solid tumor models Priority Research Paper

Outcome analysis of Phase I trial patients with metastatic KRAS and/or TP53 mutant non-small cell lung cancer Research Paper

Involvement of GLUT1-mediated glucose transport and metabolism in gefitinib resistance of non-small-cell lung cancer cells Research Paper

A novel fatty acid-binding protein 5-estrogen-related receptor Î± signaling pathway promotes cell growth and energy metabolism in prostate cancer cells Research Paper

APOBEC3B gene expression as a novel predictive factor for pathological complete response to neoadjuvant chemotherapy in breast cancer Research Paper

Positive crosstalk between EGFR and the TF-PAR2 pathway mediates resistance to cisplatin and poor survival in cervical cancer Research Paper

The DNA-polymorphism rs849142 is associated with skin toxicity induced by targeted anti-EGFR therapy using cetuximab Research Paper

CAPER as a therapeutic target for triple negative breast cancer Research Paper

Loss of KIBRA function activates EGFR signaling by inducing AREG Research Paper

A CARP-1 functional mimetic compound is synergistic with BRAF-targeting in non-small cell lung cancers Research Paper

Treatment of EGFR mutationâ€“positive nonâ€“small cell lung cancer complicated by Trousseau syndrome with gefitinib followed by osimertinib: a case report Case Report

The TGFÎ±-EGFR-Akt signaling axis plays a role in enhancing proinflammatory chemokines in triple-negative breast cancer cells Research Paper

Clinical significance of repeat rebiopsy in detecting the EGFR T790M secondary mutation in patients with non-small cell lung cancer Clinical Research Papers

Integrated treatment using intraperitoneal radioimmunotherapy and positron emission tomography-guided surgery with 64Cu-labeled cetuximab to treat early- and late-phase peritoneal dissemination in human gastrointestinal cancer xenografts Research Paper

EGFR overexpression is not common in patients with head and neck cancer. Cell lines are not representative for the clinical situation in this indication Research Paper

T790M mutant copy number quantified via ddPCR predicts outcome after osimertinib treatment in lung cancer Research Paper

Integrated treatment using intraperitoneal radioimmunotherapy and positron emission tomography-guided surgery with ⁶⁴Cu-labeled cetuximab to treat early- and late-phase peritoneal dissemination in human gastrointestinal cancer xenografts Research Paper